Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset

Human Immunology

Volumn 63, Issue 8, 2002, Pages 690-695

  Ide, Akane ^a   Kawasaki, Eiji ^b   Abiru, Norio ^b   Sun, Fuyan ^b   Takahashi, Ryoko ^a   Kuwahara, Hironaga ^a   Fujita, Naruhiro ^a   Kita, Atsushi ^a   Oshima, Katsuya ^b   Sakamaki, Hiroyuki ^a   Uotani, Shigeo ^a   Yamasaki, Hironori ^a   Yamaguchi, Yoshihiko ^a   Eguchi, Katsumi ^a  

^a Second Department of Internal Medicine   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Gene polymorphism; IL 10; Japanese; Onset age; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE; INTERLEUKIN 10; AUTOANTIBODY;

ADOLESCENT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; ADULT; ALLELE; BLOOD; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; GENE FREQUENCY; GLUTAMATE DECARBOXYLASE; HUMAN; INFANT; INTERLEUKIN-10; JAPAN; MALE; MIDDLE AGE; POLYMORPHISM (GENETICS); PROMOTER REGIONS (GENETICS); DIABETES MELLITUS, TYPE 1; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0036020525     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00417-2     Document Type: Article

References (27)

1. The pathogenesis of insulin-dependent diabetes mellitus
2. Pathogenesis of insulin-dependent (type 1) diabetes mellitus
3. A comparison of childhood and adult type 1 diabetes mellitus
4. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus
5. Evidence that the age at diagnosis of IDDM is genetically determined
6. Dissecting the genetics of type 1 diabetes: Relevance for familial clustering and differences in incidence
7. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR
8. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
9. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes
10. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
11. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
12. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
13. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells
14. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
15. IL-10: A novel cytotoxic T cell differentiation factor
16. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
17. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction
18. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
19. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice
20. Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
21. An investigation of polymorphism in the interleukin-10 gene promoter
22. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and associated with particular phenotypes of juvenile rheumatoid arthritis
23. Autoanti-bodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening
24. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus
25. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes
26. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens
27. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome